Universität zu Köln

Borchmann, Peter, Goergen, Helen, Kobe, Carsten, Lohri, Andreas, Greil, Richard, Eichenauer, Dennis A., Zijlstra, Josee M., Markova, Jana, Meissner, Julia, Feuring-Buske, Michaela, Huttmann, Andreas ORCID: 0000-0003-2230-3873, Dierlamm, Judith, Soekler, Martin, Beck, Hans-Joachim, Willenbacher, Wolfgang, Ludwig, Wolf-Dieter, Pabst, Thomas, Topp, Max S., Hitz, Felicitas, Bentz, Martin, Keller, Ulrich Bernd, Kuhnhardt, Dagmar, Ostermann, Helmut, Schmitz, Norbert, Hertenstein, Bernd, Aulitzky, Walter, Maschmeyer, Georg, Vieler, Tom, Eich, Hans, Baues, Christian, Stein, Harald, Fuchs, Michael, Kuhnert, Georg, Diehl, Volker, Dietlein, Markus and Engert, Andreas (2017). PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet, 390 (10114). S. 2790 - 2803. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

Borchmann, Peter, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Lohri, Andreas, Mey, Ulrich, Kreissl, Stefanie, Greil, Richard, Markova, Jana, Feuring-Buske, Michaela, Meissner, Julia, Duehrsen, Ulrich, Ostermann, Helmut, Keller, Ulrich, Maschmeyer, Georg, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Eich, Hans, Baues, Christian, Stein, Harald, Fuchs, Michael, Diehl, Volker and Engert, Andreas (2017). Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP(escalated) alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group. Lancet Oncol., 18 (4). S. 454 - 464. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Dietlein, Markus, Kobe, Carsten, Kuhnert, Georg, Stockter, Simone, Fischer, Thomas, Schomaecker, Klaus, Schmidt, Matthias, Dietlein, Felix, Zlatopolskiy, Boris D., Krapf, Philipp, Richarz, Raphael, Neubauer, Stephan, Drzezga, Alexander and Neumaier, Bernd ORCID: 0000-0001-5425-3116 (2015). Comparison of [F-18]DCFPyL and [Ga-68]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer. Mol. Imaging. Biol., 17 (4). S. 575 - 585. NEW YORK: SPRINGER. ISSN 1860-2002

Dronse, Julian, Fliessbach, Klaus, Bischof, Gerard N., von Reutern, Boris, Faber, Jennifer, Hammes, Jochen, Kuhnert, Georg, Neumaier, Bernd ORCID: 0000-0001-5425-3116, Onur, Oezguer A., Kukolja, Juraj ORCID: 0000-0003-1569-3287, van Eimeren, Thilo ORCID: 0000-0002-6951-2325, Jessen, Frank, Fink, Gereon R. ORCID: 0000-0002-8230-1856, Klockgether, Thomas and Drzezga, Alexander (2017). In vivo Patterns of Tau Pathology, Amyloid-beta Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease. J. Alzheimers Dis., 55 (2). S. 465 - 472. AMSTERDAM: IOS PRESS. ISSN 1875-8908

Drzezga, Alexander, Kobe, Carsten, Schmidt, Matthias, Kuhnert, Georg, Zlatopolskiy, Boris, Neumaier, Bernd and Dietlein, Markus (2016). Application of 18F-labeled PSMA-imaging using [18F]DCFPyL at very low PSA-values may allow curative treatment in recurrent prostate cancer. J. Nucl. Med., 57. RESTON: SOC NUCLEAR MEDICINE INC. ISSN 1535-5667

Eichenauer, Dennis A., Pluetschow, Annette, Kreissl, Stefanie, Soekler, Martin, Hellmuth, Johannes C. ORCID: 0000-0001-8409-3037, Meissner, Julia, Mathas, Stephan, Topp, Max S., Behringer, Karolin, Klapper, Wolfram, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2017). Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group. Lancet Oncol., 18 (12). S. 1680 - 1688. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Engert, Andreas, Kobe, Carsten, Haverkamp, Heinz, Kuhnert, Georg, Markova, Jana, Lohri, Andreas, Klutmann, Susanne, Amthauer, Holger, Diehl, Volker, Borchmann, Peter and Dietlein, Markus (2012). Relative Reduction of Residual Tumor Improves Outcome Prediction of PET After Effective Chemotherapy for Patients with Advanced Stage Hodgkin Lymphoma. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Eich, Hans, Baues, Christian, Greil, Richard, Sasse, Stephanie, Zijlstra, Josee M., Lohri, Andreas, Rosenwald, Andreas, von Tresckow, Bastian, Diehl, Volker, Kuhnert, Georg, Dietlein, Markus, Borchmann, Peter and Engert, Andreas (2018). PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Kuhnert, Georg, Lohri, Andreas, Greil, Richard, Sasse, Stephanie, Topp, Max S., Schaefer, Erhardt, Hertenstein, Bernd, Soekler, Martin, Vogelhuber, Martin, Zijlstra, Josee M., Keller, Ulrich Bernd, Krause, Stefan W., Wilhelm, Martin, Maschmeyer, Georg, Thiemer, Julia, Duehrsen, Ulrich, Meissner, Julia, Viardot, Andreas, Eich, Hans, Baues, Christian, Diehl, Volker, Rosenwald, Andreas, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter and Engert, Andreas (2019). Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. J. Clin. Oncol., 37 (31). S. 2835 - 2847. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kahraman, Deniz, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Rothe, Achim, Kuhnert, Georg, Sasse, Stephanie, Scheid, Christoph, Dietlein, Markus, Drzezga, Alexander, von Bergwelt-Baildon, Michael and Kobe, Carsten (2014). 18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma. Leuk. Lymphoma, 55 (4). S. 811 - 817. LONDON: INFORMA HEALTHCARE. ISSN 1029-2403

Kobe, Carsten, Boellaard, Ronald ORCID: 0000-0002-0313-5686, Wolf, Juergen, Kuhnert, Georg, Dietlein, Markus, Neumaier, Bernd ORCID: 0000-0001-5425-3116, Drzezga, Alexander and Kahraman, Deniz (2015). Developments in oncological positron emission tomography/computed tomography assessment. J. Thorac. Dis., 7 (12). S. E637 - 3. HONG KONG: PIONEER BIOSCIENCE PUBL CO. ISSN 2077-6624

Kobe, Carsten, Goergen, Helen, Baues, Christian, Kuhnert, Georg, Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Zijlstra, Josee, Hoekstra, Otto, Mettler, Jasmin, Drzezga, Alexander, Engert, Andreas, Borchmann, Peter and Dietlein, Markus (2018). Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma. Blood, 132 (21). S. 2273 - 2280. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kobe, Carsten, Kuhnert, Georg, Kahraman, Deniz, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Eich, Hans-Theodor, Franke, Mareike, Persigehl, Thorsten, Klutmann, Susanne, Amthauer, Holger, Bockisch, Andreas, Kluge, Regine, Wolf, Hans-Heinrich, Maintz, David, Fuchs, Michael, Borchmann, Peter, Diehl, Volker, Drzezga, Alexander, Engert, Andreas and Dietlein, Markus (2014). Assessment of Tumor Size Reduction Improves Outcome Prediction of Positron Emission Tomography/Computed Tomography After Chemotherapy in Advanced-Stage Hodgkin Lymphoma. J. Clin. Oncol., 32 (17). S. 1776 - 1782. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kuhnert, Georg, Boellaard, Ronald ORCID: 0000-0002-0313-5686, Sterzer, Sergej, Kahraman, Deniz, Scheffler, Matthias ORCID: 0000-0002-9031-1368, Wolf, Juergen, Dietlein, Markus, Drzezga, Alexander and Kobe, Carsten (2016). Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis. Eur. J. Nucl. Med. Mol. Imaging, 43 (2). S. 249 - 259. NEW YORK: SPRINGER. ISSN 1619-7089

Kuhnert, Georg, Boellaard, Ronald ORCID: 0000-0002-0313-5686, Sterzer, Sergej, Kahraman, Deniz, Scheffler, Matthias ORCID: 0000-0002-9031-1368, Wolf, Juergen, Dietlein, Markus, Drzezga, Alexander and Kobe, Carsten (2016). Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis (vol 43, pg 249, 2016). Eur. J. Nucl. Med. Mol. Imaging, 43 (1). S. 204 - 206. NEW YORK: SPRINGER. ISSN 1619-7089

Mettler, Jasmin, Mueller, Horst, Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Baues, Christian, Klaeser, Bernd, Moccia, Alden, Borchmann, Peter, Engert, Andreas, Kuhnert, Georg, Drzezga, Alexander, Dietlein, Markus and Kobe, Carsten (2019). Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma. J. Nucl. Med., 60 (2). S. 207 - 212. RESTON: SOC NUCLEAR MEDICINE INC. ISSN 1535-5667

Rothe, Achim, Sasse, Stephanie, Topp, Max S., Eichenauer, Dennis A., Hummel, Horst, Reiners, Katrin S., Dietlein, Markus, Kuhnert, Georg, Kessler, Joerg, Buerkle, Carolin, Ravic, Miroslav, Knackmuss, Stefan, Marschner, Jens-Peter, von Strandmann, Elke Pogge, Borchmann, Peter and Engert, Andreas (2015). A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma. Blood, 125 (26). S. 4024 - 4032. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Sasse, Stephanie, Rothe, Achim, Goergen, Helen, Eichenauer, Dennis A., Lohri, Andreas, Kreher, Stephan, Jaeger, Ulrich, Bangard, Christopher, Kuhnert, Georg, Boell, Boris, von Tresckow, Bastian and Engert, Andreas (2013). Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphoma. Leuk. Lymphoma, 54 (10). S. 2144 - 2149. LONDON: INFORMA HEALTHCARE. ISSN 1042-8194

Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Mettler, Jasmin, Boellaard, Ronald ORCID: 0000-0002-0313-5686, Kuhnert, Georg, Dietlein, Markus, Borchmann, Peter, Drzezga, Alexander and Kobe, Carsten (2019). Quantitative assessment of F-18-FDG PET in patients with Hodgkin lymphoma: is it significantly affected by contrast-enhanced computed tomography attenuation correction? Nucl. Med. Commun., 40 (3). S. 249 - 258. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1473-5628

von Tresckow, Bastian, Pluetschow, Annette, Haverkamp, Heinz, Vucinic, Vladan, Rank, Andreas, Topp, Max S., Feuring-Buske, Michaela, Kobe, Carsten, Kuhnert, Georg, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2014). A Phase I Study of Everolimus in Combination with Time-Intensified DHAP ( Dexamethasone, High-Dose AraC [Cytarabine], Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (cHL). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020